Buroker T - Search Results

1

Phase I trial of ftorafur combined with mitomycin C or methyl-CCNU in gastrointestinal cancers.

Buroker T, Baker L, Correa J, Schwartz LA, Vailtkevicius VK. Buroker T, et al. Cancer Treat Rep. 1977 May-Jun;61(3):463-7. Cancer Treat Rep. 1977. PMID: 326403 Clinical Trial.

2

Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer.

Buroker T, Wojtaszak B, Dindogru A, DeMattia M, Baker L, Groth C, Vaitkevicius VK. Buroker T, et al. Cancer Treat Rep. 1978 May;62(5):689-92. Cancer Treat Rep. 1978. PMID: 350398 Clinical Trial.

3

Phase II clinical trial of ftorafur in 5-fluorouracil-refractory colorectal cancer.

Buroker T, Miller A, Baker L, McKenzie M, Samson M, Vaitkevicius VK. Buroker T, et al. Cancer Treat Rep. 1977 Nov;61(8):1579-80. Cancer Treat Rep. 1977. PMID: 336199 No abstract available.

4

Phase II study of Baker's antifol in advanced colorectal cancer.

Padilla F, Correa J, Buroker T, Vaitkevicius VK. Padilla F, et al. Among authors: buroker t. Cancer Treat Rep. 1978 Apr;62(4):553-4. Cancer Treat Rep. 1978. PMID: 350391 Clinical Trial. No abstract available.

5

Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875).

Samson MK, Baker LH, Devos JM, Buroker TR, Izbicki RM, Vaitkevicius VK. Samson MK, et al. Among authors: buroker tr. Cancer Treat Rep. 1976 Jan;60(1):91-7. Cancer Treat Rep. 1976. PMID: 63332 Clinical Trial.

6

Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestine.

Fraile RJ, Samson MK, Buroker TR, O'Bryan R, Baker LH, Vaitkevicius VK. Fraile RJ, et al. Among authors: buroker tr. Cancer Treat Rep. 1978 Oct;62(10):1599-601. Cancer Treat Rep. 1978. PMID: 361229 Clinical Trial.

7

Hepatic artery infusion of 5-FUDR after prior systemic 5-fluorouracil.

Buroker T, Samson M, Correa J, Fraile R, Vaitkevicius VK. Buroker T, et al. Cancer Treat Rep. 1976 Sep;60(9):1277-9. Cancer Treat Rep. 1976. PMID: 138480 Clinical Trial.

8

Mitomycin-C alone and in combination with infused 5-fluorouracil to the treatment of disseminated gastrointestinal carcinomas.

Buroker TR, Kim PN, Baker LH, Ratanatharathron V, Wojtaszak B, Vaitkevicius VK. Buroker TR, et al. Med Pediatr Oncol. 1978;4(1):35-42. doi: 10.1002/mpo.2950040107. Med Pediatr Oncol. 1978. PMID: 342890 Clinical Trial.

9

Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion.

Fraile RJ, Baker LH, Buroker TR, Horwitz J, Vaitkevicius VK. Fraile RJ, et al. Among authors: buroker tr. Cancer Res. 1980 Jul;40(7):2223-8. Cancer Res. 1980. PMID: 7388790

10

5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study.

Buroker T, Kim PN, Groppe C, McCracken J, O'Bryan R, Panettiere F, Costanzi J, Bottomley R, King GW, Bonnet J, Thigpen T, Whitecar J, Haas C, Vaitkevicius VK, Hoogstraten B, Heilbrun L. Buroker T, et al. Cancer. 1979 Oct;44(4):1215-21. doi: 10.1002/1097-0142(197910)44:4<1215::aid-cncr2820440408>3.0.co;2-s. Cancer. 1979. PMID: 387204 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters